Revenue: The sum of all revenue fields included for a company's operating activities.
Taysha Gene Therapies, Inc. (TSHA) had Revenue of $8.33M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$8.33M |
$-89.30M |
|
-- |
|
$8.33M |
|
$99.79M |
|
$-91.46M |
|
$2.16M |
|
$-89.30M |
|
$-89.30M |
|
$-89.30M |
|
$-89.30M |
|
$-89.30M |
|
$-89.30M |
|
$-91.46M |
|
$-90.21M |
|
250.13M |
|
250.13M |
|
$-0.36 |
|
$-0.36 |
|
| Balance Sheet Financials | |
$142.13M |
|
$7.49M |
|
$18.23M |
|
$160.36M |
|
$26.23M |
|
$43.94M |
|
$62.61M |
|
$88.84M |
|
$71.53M |
|
$71.53M |
|
$71.53M |
|
204.94M |
|
| Cash Flow Statement Financials | |
$-81.22M |
|
$-0.36M |
|
$76.68M |
|
$146.54M |
|
$141.64M |
|
$-4.90M |
|
$13.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.42 |
|
-- |
|
-- |
|
0.38 |
|
0.61 |
|
100.00% |
|
-1097.55% |
|
-1097.55% |
|
-1082.61% |
|
-1071.62% |
|
-1071.62% |
|
$-81.60M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
-- |
|
-- |
|
-124.85% |
|
-124.85% |
|
-55.68% |
|
-77.34% |
|
$0.35 |
|
$-0.33 |
|
$-0.32 |
|